Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research Post published:February 25, 2021 Post category:Press Release
PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange Post published:February 25, 2021 Post category:Press Release
Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil Post published:February 25, 2021 Post category:Press Release
Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness Post published:February 25, 2021 Post category:Press Release
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy Post published:February 25, 2021 Post category:Press Release
Nova Mentis Autism Clinical Study Approved by Institutional Review Board Post published:February 25, 2021 Post category:Press Release
Center for Psychedelic Medicine Established at NYU Langone Health Post published:February 24, 2021 Post category:Press Release
Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing Post published:February 24, 2021 Post category:Press Release
Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences Post published:February 24, 2021 Post category:Press Release
Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference Post published:February 24, 2021 Post category:Press Release